Sano M, Kumamoto Y, Nishimura M, Tsukamoto T, Hirose T, Ohya S
Department of Urology, Sapporo Medical University, School of Medicine.
Kansenshogaku Zasshi. 1994 Nov;68(11):1306-17. doi: 10.11150/kansenshogakuzasshi1970.68.1306.
The role of clarithromycin (CAM) in biofilm formation has recently been reported. Inhibition of the production or promotion of the dissolution of the glycocalyx, a major component of biofilm, has been implicated in its mechanism of action. However, the details remain unclear. We used an experimental model of complicated urinary bladder infection and automated simulation of the variations in urinary antimicrobial concentration to study the efficacy of CMA in inhibiting biofilm formation and obtained the following results. 1) Prior to biofilm formation, Pseudomonas aeruginosa (P. aeruginosa) was exposed to ciprofloxacin (CPFX, MIC: 8 micrograms/ml), which was active against the organism, at a dose of 200 mg t.i.d. for 7 days. The bacteria were apparently eradicated from the culture medium in the experimental model of bladder infection (model bladder) after 32 hours. However, when the medium was changed to eliminate the antimicrobial agent on Day 7, bacterial regrowth was initiated after 4 hours. Scanning electron microscopy demonstrated sequential biofilm formation on the surface of glass beads in the model bladder diverticulumn, suggesting inside the biofilm were a source of regrowth. 2) Prior to biofilm formation, P. aeruginosa was also exposed to CAM alone, which has no antimicrobial activity against the organism (MIC: > 128 micrograms/ml) at a dose of 200 mg t.i.d. for 7 days. In this situation, CAM was not active against P. aeruginosa and the bactericidal concentration in the model bladder did not decrease markedly, reaching the initial level (10(7) CFU/ml) within 48 hours. However, although numerous bacteria were attached to the glass beads in the diverticulum, no biofilm was formed. 3) Exposure to a combination of CPFX and CAM (each at 200 mg t.i.d. for 7 days) resulted in the eradication of bacteria from the model bladder at 32 hours, and no bacterial regrowth was demonstrated after the medium was exchanged on Day 7. In addition, no biofilm was formed and the bacteria did not become attached to the glass beads. 4) The content of alginate, a major component of P. aeruginosa biofilm, was measured per 5 glass beads on Day 3, 5, and 7 after starting drug administration. The alginate content increased with time when CPFX was given alone at a dose of 200 mg t.i.d..(ABSTRACT TRUNCATED AT 400 WORDS)
最近有报道称克拉霉素(CAM)在生物膜形成中所起的作用。其作用机制涉及抑制作为生物膜主要成分的糖萼的产生或促进其溶解。然而,具体细节仍不清楚。我们使用复杂性膀胱感染的实验模型以及尿液抗菌浓度变化的自动模拟来研究CAM抑制生物膜形成的效果,得到以下结果。1)在生物膜形成之前,将铜绿假单胞菌暴露于对该菌有活性的环丙沙星(CPFX,MIC:8微克/毫升),剂量为200毫克,每日三次,持续7天。在膀胱感染实验模型(模型膀胱)中,32小时后细菌明显从培养基中被清除。然而,在第7天更换培养基以去除抗菌剂后,4小时后细菌开始重新生长。扫描电子显微镜显示在模型膀胱憩室的玻璃珠表面有生物膜依次形成,提示生物膜内部是细菌重新生长的来源。2)在生物膜形成之前,也将铜绿假单胞菌单独暴露于对该菌无抗菌活性的CAM(MIC:>128微克/毫升),剂量为200毫克,每日三次,持续7天。在这种情况下,CAM对铜绿假单胞菌无活性,模型膀胱中的杀菌浓度没有明显下降,在48小时内达到初始水平(10⁷CFU/毫升)。然而,尽管憩室中有大量细菌附着在玻璃珠上,但未形成生物膜。3)暴露于CPFX和CAM的组合(各200毫克,每日三次,持续7天)导致32小时后模型膀胱中的细菌被清除,在第7天更换培养基后未显示细菌重新生长。此外,未形成生物膜,细菌也未附着在玻璃珠上。4)在开始给药后的第3、5和7天,每5个玻璃珠测量铜绿假单胞菌生物膜的主要成分藻酸盐的含量。当单独给予CPFX,剂量为200毫克,每日三次时,藻酸盐含量随时间增加。(摘要截取自400字)